Cite

HARVARD Citation

    Tsaur, I. et al. (2021). A real‐world comparison of docetaxel versus abiraterone acetate for metastatic hormone‐sensitive prostate cancer. Cancer medicine. pp. 6354-6364. [Online]. 
  
Back to record